Recall of a batch of an antiepileptic drug due to risk of overdose

A batch of Micropakine, an antiepileptic drug, has been withdrawn due to the risk of overdose linked to taking too full sachets, which can cause drowsiness or lethargy, the report said Friday. Medicines Agency (ANSM).This is batch No. DM0059 of Micropakine LP 500mg with expiration date March 2022 and sold in boxes of 30 sachets.

The recall of this drug from the Sanofi-Aventis France laboratory follows on discovered by patients in two boxes of both empty sachets and sachets too full of sodium valproate granules – the same active ingredient as Dépakine, at the center of a health scandal, which should be avoided during pregnancy. These anomalies have been confirmed by investigations, notes the health agency.

Taking this medicine with a sachet that is too full may cause the patient to overdose with valproate., ANSM points out. Affected patients should therefore return the batch boxes to their pharmacy as soon as possible for a free exchange, so as not to interrupt their treatment. If the patient cannot go to the pharmacy, he should contact the pharmacist or treating doctor.

Sanofi-Aventis France, in agreement with ANSM, has also asked pharmacists and dispensing pharmacies of health facilities to contact, by all means at their disposal, patients who may have and / or have used the specialty of game affected by this recall. The weight of the double-filled sachets corresponds to the weight of the 1000 mg Micropakine LP sachets.

Sodium valproate overdose results in drowsiness or lethargyadds ANSM. Advise patients taking this granular treatment of “
contact your doctor as soon as possible if you have any unusual symptoms.“”To date, no cases of adverse effects related to this defect have been reported to ANSM.
», Specify the latter.